Dana Delaski, MSN, FNP-BC, shares insights on how once-daily ruxolitinib, self-injected rusfertide, and givinostat will transform PV clinic workflows.
Dana Delaski, MSN, FNP-BC
Advertisement
Articles by Dana Delaski, MSN, FNP-BC
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Iberdomide: A New Oral Paradigm in Multiple Myeloma Care
2
FDA Approves Camizestrant for ESR1-Mutated Advanced Breast Cancer
3
Oncology Clinicians Must Prioritize Survivorship Lifestyle Discussions
4
Nursing Protocols for the New Oral RAS Inhibitor Daraxonrasib
5